Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification

MLA

Lu, Hsin-Yu, et al. “Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification.” Blood, vol. 142, no. 1, Number 1 Supplement 1, Nov. 2023, p. 1878. EBSCOhost, https://doi.org/10.1182/blood-2023-186106.

APA

Lu, H.-Y., Lee, W. H., Lin, C.-C., Tsai, C.-H., Tien, F.-M., Lo, M. Y., Tseng, M.-H., Kuo, Y.-Y., Yu, S.-C., Liu, M.-C., Yuan, C.-T., Yang, Y.-T., Chuang, M.-K., Tang, J.-L., Sun, H.-I., Chuang, Y.-K., Hou, H.-A., Tien, H.-F., & Chou, W.-C. (2023). Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification. Blood, 142(1, Number 1 Supplement 1), 1878. https://doi.org/10.1182/blood-2023-186106

Chicago

Lu, Hsin-Yu, Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min Yen Lo, Mei-Hsuan Tseng, et al. 2023. “Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification.” Blood 142 (1, Number 1 Supplement 1): 1878. doi:10.1182/blood-2023-186106.